Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.1260
+0.0310 (32.63%)
Feb 12, 2026, 9:30 AM EST
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $718.01 thousand as of February 13, 2026. Its market cap has decreased by -52.02% in one year.
Market Cap
718.01K
Enterprise Value
1.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
Market Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 718.01K, a decrease of -99.58%. That is a compound annual growth rate of -37.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 560.12K | 5.96% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagenic Therapeutics | 944.67K |
| Lipella Pharmaceuticals | 878.42K |
| EV Biologics | 840.53K |
| Aibotics | 717.45K |
| SQZ Biotechnologies Company | 707.79K |
| Sorrento Therapeutics | 706.83K |
| Helix BioMedix | 606.71K |
| Bio-Path Holdings | 536.05K |